China Securities Network News (reporter Wang Bo) Berry Gene (000710) announced on the evening of October 29 that it is expected that the net profit attributable to the shareholders of listed companies in 2021 will be 60 million yuan - 90 million yuan, compared with a profit of 211 million yuan in the same period last year; the basic earnings per share - 0.25 yuan to -0.17 yuan.
The company said that the implementation of equity incentives during the reporting period is expected to affect the company's net profit by about 27.94 million yuan; it is expected to recognize investment losses of about 62 million yuan for the participating subsidiaries such as Fujian Herui Gene Technology Co., Ltd. for the whole year.